Current Medicinal Chemistry
Title:Drug Repurposing in Vasculo-metabolic Diseases
Volume: 30 Issue: 35
Author(s): Ali H. Eid
Affiliation:
Export Options
About this article
Cite this article as:
Eid H. Ali, Drug Repurposing in Vasculo-metabolic Diseases, Current Medicinal Chemistry 2023; 30 (35) . https://dx.doi.org/10.2174/092986733035230504164038
DOI https://dx.doi.org/10.2174/092986733035230504164038 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Identifying TMPRSS2 Inhibitors by Drug Repurposing Screenings of
Known fXIa Inhibitors: A Computational Study
Letters in Drug Design & Discovery Molecular Targeting of Aberrant Transcription Factors in Leukemia: Strategies for RUNX1/ETO
Current Drug Targets Clinical Uses of Melatonin: Evaluation of Human Trials
Current Medicinal Chemistry Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
Current Vascular Pharmacology Prevention Knowledge and Its Practice Towards COVID-19 Among General Population of Saudi Arabia: A Gender-based Perspective
Current Pharmaceutical Design A Comparative Analysis of Protein Interfaces
Protein & Peptide Letters Mitochondria in Cancer Stem Cells: A Target for Therapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Graphical Abstracts
Letters in Drug Design & Discovery Tissue Factor and COVID-19: An Update
Current Drug Targets Ocular COVID-19: Eyes as a Reservoir to Conceal and Spread SARSCoV- 2
Infectious Disorders - Drug Targets The World Against Versatile SARS-Cov-2 Nanomachines: Mythological or Reality?
Current Stem Cell Research & Therapy Discovery of 8-methoxypyrazino[1,2-a]indole as a New Potent Antiproliferative Agent Against Human Leukemia K562 Cells. A Structure-Activity Relationship Study
Letters in Drug Design & Discovery Smart Biodecorated Hybrid Nanoparticles
Current Bionanotechnology (Discontinued) The Use of Computational Methods in the Discovery and Design of Kinase Inhibitors
Current Pharmaceutical Design Recent Applications of 2,2-Disubstituted-1,3-Dicarbonyls
Current Organic Chemistry Treatment of Pulmonary Edema by ENaC Activators/Stimulators
Current Molecular Pharmacology Small Molecules for Interference with Cell-Cell-Communication Systems in Gram-Negative Bacteria
Current Medicinal Chemistry A Structure-Affinity and Comparative Molecular Field Analysis of Sigma-2 (σ2) Receptor Ligands
Central Nervous System Agents in Medicinal Chemistry Chemical and Biological Properties of Phenolics in Wine: Analytical Determinations and Health Benefits
Current Organic Chemistry Tetracyclines and Pulmonary Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets